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ABSTRACT The Republic of Panama has the second most unequally distributed wealth in Central America, has recently 
entered the list of countries affected by the COVID-19 pandemic, and has one of the largest testing rate per 
inhabitant in the region and consequently the highest incidence rate of COVID-19, making it an ideal location 
to discuss potential scenarios for assessing epidemic preparedness, and to outline research opportunities 
in the Region of the Americas. We address two timely important questions: What are the unique risks of 
COVID-19 in Panama that could help other countries in the Region be better prepared? And what kind of sci-
entific knowledge can Panama contribute to the regional and global study of COVID-19? This paper provides 
suggestions about how the research community could support local health authorities plan for different sce-
narios and decrease public anxiety. It also presents basic scientific opportunities about emerging pandemic 
pathogens towards promoting global health from the perspective of a middle income country.
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The severe acute respiratory syndrome coronavirus two 
(SARS-CoV-2), responsible for the current COVID-19 pan-
demic, has affected more than 100 countries, infected more than 
3.8 million people and killed more than 260 000 as of May 8, 
2020 (1). Globally, an average lethality rate of 6.9 % is reported, 
but the numbers vary widely per country (1) (Figure 1). ln 
the first few months, the pandemic affected mainly wealthier 
countries from the northern hemisphere, but it recently has 
started to take a hold of the southern hemisphere where poorer, 
less developed countries are located, including those in Latin 
America (2).
Latin America has the highest income inequality of any region 
on Earth (3). This part of the world is particularly vulnerable to 
the COVID-19 pandemic due to a large portion of the population 
being exposed to a high burden of disease, lack of clean, potable 
water and sanitation, poor infrastructure and limited access to 
qualified health personnel to manage the crisis and transmis-
sion of the disease (4). The country of Panama has the second 
most unequally distributed wealth in Central America (5), has 
recently entered the list of countries affected by the COVID-19 
pandemic, and has one of the largest testing rate per inhabi-
tant in the region and consequently one of the highest number 
of detected cases of COVID-19, making it an ideal location to 
discuss potential scenarios for assessing epidemic preparedness, 
and to outline research opportunities in the region.
The capital city of Panama is the second most populous city 
in Central America and a hub of international trade and tour-
ism. Panama city has a metropolitan population of 1.6 million 
people and approximately 2.5 million visitors arriving to the 
city from abroad year-round (5).The Ministry of Health in 
Panama (MINSA, http://www.minsa.gob.pa), with the sup-
port of the Pan-American Health Organization/World Health 
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Organization (PAHO/WHO), established a strong containment 
strategy to cover all ports of entry into the country since early 
January 2020 (6). As of May 11, 2020, SARS-CoV-2 has already 
infected over 8 616 people around Panama City, and over 249 
people have died (7).
Herein, we address two timely important questions: What 
are the unique risks of COVID-19 in Panama that could help 
other countries in the region be better prepared? And what kind 
of scientific knowledge can Panama contribute to the regional 
and global study of COVID-19? This paper provides sugges-
tions about how the research community could support local 
health authorities plan for different scenarios and decrease pub-
lic anxiety. It also presents basic scientific opportunities about 
emerging pandemic pathogens towards promoting global 
health from the perspective of a middle-income country.
The WHO has released a report titled “A Coordinated Global 
Research Roadmap” that presents a comprehensive collabo-
rative research agenda to address the COVID-19 pandemic 
that should be integrated into the response from the start, and 
implemented as policy and practice to save lives and be better 
prepared for future outbreaks (8). The risk and research oppor-
tunities described in the following paragraphs are contained 
and aligned with the Global Research Roadmap following and 
presented in the format of immediate, mid-term and long-term 
research priorities, while adapted to the experience and reality 
of Panama and Latin America.
IMMEDIATE RESEARCH PRIORITIES
Active Surveillance of the Disease
Understanding viral spread through human communities 
with different demographic and socioeconomic backgrounds, 
gender, age groups and geographic landscapes will help sci-
entists recognize the dynamic (e.g., mode and speed) of 
person-to-person transmission and the behaviors that may 
expose or protect people from getting the infection. Scientific 
institutions in the region along with local health authorities 
would benefit from conducting active surveillance of SARS-
CoV-2 infections on a significant portion of the population, 
including vulnerable populations such as indigenous communi-
ties, and even consider testing sera samples stored in reference 
laboratories for seroprevalence studies. However, this will require 
enough resources for a stable supply of diagnostic kits and other 
associated reagents, or the development of local capacities and 
inventories that could help circumvent global shortages.
Figure 1. Lethality rate (%) and GINI Index across countries affected by COVID-19 in countries from Central America, South America 
and the Northern Hemisphere.
Source: data from https://ourworldindata.org/covid-testing and https://data.worldbank.org/indicator/SI.POV.GINI.
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Social Science-Based Mitigation Strategies
The main goal of social distancing actions is to slow the 
transmission rate of the virus for 14 to 20 days after a cluster 
of activity has been identified and to protect healthcare system 
capacity rates. Although health authorities in Panama, Costa 
Rica and just a handful of other countries in the region seem to 
be approaching that goal in this initial encounter with the pan-
demic, most countries should still prepare for the worst-case 
scenario: a significant increase of new cases and deaths a few 
weeks after the suspension of the quarantines and the economic 
reactivation of the Region. This scenario, although pessimistic, 
is currently being reported in several countries, such as South 
Korea, Germany and Singapore, forcing their health authorities 
to enforce lockdowns once again.
Communication of all types (e.g., including social media’s 
effects on policing), and enforcement of these strict mitiga-
tion scenarios is fertile territory for social science research to 
understand how people across the socioeconomic and cultural 
spectrum adopt these mandates to help maximize compliance 
and ensure the most vulnerable, including rural and indige-
nous communities, are not left behind. Due to its huge impact 
in ordinary life, social media could foster new ways of collect-
ing data, raising the possibility of mass surveillance, while 
upholding the right to privacy and helping to strengthen estab-
lished policies to mitigate the transmission of SARS-CoV-2 (14). 
A study could be performed where images, communications, 
geographic location or related data from social networks are 
retrieved, encoded and analyzed to predict when and where 
future cases, clusters or community transmission of SARS-
CoV-2 might occur through space and time. The aim of these 
efforts is to identify people from different gender, age, job occu-
pation, socioeconomic or demographic backgrounds that might 
be involved in efficient disease spread.
LONG-TERM RESEARCH PRIORITIES
Dynamics of Community Transmission
Although the contacts made by the index case or “patient 
zero” have not been entirely elucidated in Panama, the coun-
try has quickly entered the more advanced epidemiological 
scenarios of SARS-CoV-2 community transmission. Attempts 
to prevent the spread of the virus are no longer focused only 
on close contacts to confirmed cases within households or 
work-related spaces, as the health authorities in the coun-
try closed down schools nationwide a few days after the first 
officially reported epidemic cluster was reported. Strict social 
distancing interventions, including absolute quarantines 
during weekends and curfews based on gender and personal 
identification numbers, have been implemented based on the 
epidemiological evidence being analyzed by scientists, epide-
miologists, intensive care physicians and experts from PAHO/
WHO that are part of the Advisory Scientific Committee offering 
recommendations to the Ministry of Health. The government 
is promoting that public offices and businesses take advantage 
of recently passed work-from-home legislation, accelerating a 
digitalization agenda that had been advocated for years. While 
such plans seem easy to achieve in small countries like Pan-
ama, the large number of people that travel across space when 
economies start to reactivate and during upcoming festivals 
A scientific strategy to gather samples using random active 
surveillance (e.g., randomized surveillance of patients with 
acute respiratory disease or flu-like illness) from across the 
country will allow an assessment of the true burden of dis-
ease by documenting asymptomatic infections, including areas 
where the virus may have been unnoticed and circulating pre-
viously. This is also a great opportunity to co-monitor zoonotic 
viral illnesses such as other coronaviruses (229E, HKU1, OC43, 
NL63), adenovirus, human rhinovirus/enterovirus, influenza 
A, influenza A/H1, flu-A-H1 2009 and influenza B, which could 
help to understand their dynamics in real time. Similar strate-
gies have already been implemented in countries that are now 
showing a declining number of infections and deaths, such as 
South Korea and China with their mobile, drive-through fever 
clinics for triaging patients (9). Interestingly, a scenario of active 
surveillance has already been reported for other emerging 
infectious pathogens in Panama (10).
MID-TERM RESEARCH PRIORITIES
Virus Evolution and Multiple Entries
SARS-CoV-2 will likely arrive into Panama City multiple 
times due to its constant influx of potentially infected cases 
and its international business environment, based around the 
Panama Canal and its financial sector, supporting year-round 
economic activities. A scenario of multiple introductions can 
allow scientists to tackle fundamental questions of virus evo-
lution and demography. For example, are several strains of 
SARS-CoV-2 co-circulating in the isthmus, or is there a single 
strain that amplifies? Publicly available data from Nextstrain 
(https://nextstrain.org) shows that the population expansion 
of SARS-CoV-2 is ongoing (e.g., branching events as the virus 
acquired genetic mutations when entering new geographic 
regions), and that novel mutations arising from epidemic coun-
tries in four continents could be introduced into Panama, with 
no scientific knowledge on the potential consequences for viral 
evolution (e.g., genetic recombination among strains coming 
from different geographic regions co-infecting a host), includ-
ing transmission and pathogenicity.
Most countries have restricted or suspended international 
flights, and barred entrance to non-citizens/non-residents. Yet, 
countries borders cannot remain closed indefinitely, and the risk 
of introducing foreign positive cases will remain a constant fac-
tor for every country in the Region once they start reactivating 
their economies. Surveillance strategies at the ports of entry can 
be highly ineffective due to a prolonged incubation period of 
14 days or more, allowing the virus to spread silently and rap-
idly across space and time (11). Indeed, mathematical modeling 
shows that the expected effectiveness of screening for COVID-19 
at airports at best will miss 50 to 70% of cases (12), highlight-
ing the importance of active surveillance strategies discussed 
in the previous section. This also raises the question of the role 
of over-land movements, both between and within countries 
versus aviation transportation in the spread and containment of 
COVID-19 in Latin America. Instances of over-land movement 
of infectious disease pathogens into and through Panama has 
been reported in the past (13). An epidemiological study using 
samples collected through space and time, especially during the 
first 12 months of invasion as well as seasonally, will be crucial 
to answering some of these important scientific questions.
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for the local scientific community to contribute knowledge to 
the global study of COVID-19, which could better prepare the 
world to face the never-ending battle against novel pandemic 
pathogens.
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and religious celebrations still makes them hard to implement. 
Scientific information could be gathered to study the dynamic 
demographic scenario supporting community transmission 
over long geographic distances and across time during the reac-
tivation period.
The application of geographic methods, increasingly useful 
in examining the spatial epidemiology of infectious diseases, 
such as remote sensing (RS) and Geographic Information Sys-
tems (GIS), could complement research efforts about COVID-19 
disease epidemiology in the region. The introduction of a 
health authority-approved innovative mobile app that could be 
quickly adopted by most of the population and those entering 
the country, could promote people with mild symptoms shar-
ing information about their health status without having to go 
to the emergency room, and could serve as unique platforms to 
monitor and track suspected cases. Possible studies that quantify 
the risk of infection for people travelling from and into epidemic 
areas and comparing them to people that have not travelled long 
distances during the same period of time, could offer indexes 
with predicting capabilities that would justify restricting access 
to certain areas of the country or cancelling popular events.
CONCLUSIONS
SARS-CoV-2 virus is adversely impacting the public health 
systems in Latin American countries, and we must remain 
calm while carefully recognizing the lessons learned from 
other regions to avoid human casualties. These, by far, are 
not the only research questions included in the WHO Global 
Research Roadmap that need to be addressed by the evolv-
ing scientific community in a region where investment in 
information communications technology should increase to 
leverage the true value of scientific research in moments of 
global emergency. This difficult time can be a great opportunity 
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La pandemia de COVID-19 en Panamá: lecciones basadas en los riesgos y las 
oportunidades de investigación singulares en América Latina
RESUMEN La República de Panamá es el segundo país de Centroamérica con la distribución más desigual de la riqueza, 
ha resultado afectado recientemente por la pandemia de COVID-19 y tiene una de las mayores tasas de 
pruebas diagnósticas por habitante de la región y, por consiguiente, la mayor tasa de incidencia de COVID-19. 
Estos aspectos la convierten en un lugar ideal para examinar posibles escenarios de evaluación de la prepa-
ración para la epidemia y para plantear oportunidades de investigación en la Región de las Américas. Se 
abordan dos preguntas importantes y oportunas: ¿Cuáles son los riesgos singulares de la COVID-19 en Pan-
amá que podrían ayudar a otros países de la Región a estar mejor preparados? y ¿Qué tipo de conocimiento 
científico puede aportar Panamá al estudio regional y mundial de la COVID-19? En este artículo se presentan 
sugerencias sobre la forma en que la comunidad de investigadores podría apoyar a las autoridades sanitar-
ias locales a planificar medidas ante diferentes escenarios y disminuir la ansiedad de la población. También 
se presentan oportunidades científicas básicas sobre patógenos pandémicos emergentes para promover la 
salud mundial desde la perspectiva de un país de ingresos medios.
Palabras clave Infecciones por coronavirus; virosis; pandemias; virus del SRAS; investigación; Américas
